Allergy/Imm

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Berger WE et al. - All treatments reduced albuterol use and nighttime awakenings and improved asthma symptom scores; these improvements were greater for CIC80 b.i.d. than for placebo. The incidence of adverse events was similar among treatment groups. In this study, CIC80 b.i.d. improved disease control in subjects with mild-to-moderate persistent asthma not using an ICS and provided greater improvements than CIC160 q.d.


Today in Cardiovascular/Pulm...keeping you current

Role of adenoids and adenoiditis in children with allergy and otitis media
Current Allergy and Asthma Reports, 10/22/09

Pediatric Asthma: An Integrative Approach to Care
Nutrition in Clinical Practice, 10/22/09

From asthma severity to control: a shift in clinical practice
Primary Care Respiratory Journal, 10/19/09

Today in Clinical Pharmacology...keeping you current

Novel Therapies for Pemphigus Vulgaris: An Overview
Drugs & Aging, 09/21/09

Zinc: role in immunity, oxidative stress and chronic inflammation
Current Opinion in Clinical Nutrition & Metabolic Care, 10/21/09

Anti-Inflammatory Drugs in Psychiatry
Inflammation & Allergy - Drug Targets, 10/09/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address